The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function

• Annkristin Heine ,

  Contributed equally to this work with: Annkristin Heine, Stefanie Andrea Erika Held

  * E-mail: annkristin.heine@ukb.uni-bonn.de

  Affiliation Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

  ⨯
• Stefanie Andrea Erika Held ,

  Contributed equally to this work with: Annkristin Heine, Stefanie Andrea Erika Held

  Affiliation Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

  ⨯
• Solveig Nora Daecke,

  Affiliation Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

  ⨯
• Kati Riethausen,

  Affiliation Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

  ⨯
• Philipp Kotthoff,

  Affiliation Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

  ⨯
• Chrystel Flores,

  Affiliation Institute of Experimental Immunology (IEI), University Bonn, Bonn, Germany

  ⨯
• Christian Kurts,

  Affiliation Institute of Experimental Immunology (IEI), University Bonn, Bonn, Germany

  ⨯
• Peter Brossart

  Affiliation Department of Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany

  ⨯